(64 days)
iSR'obot Mona Lisa 2.0 is a user-controlled, stereotaxic accessory intended to guide physicians in the planning and positioning of insertion tools, such as a third-party needle or a probe, during image-guided diagnostic and interventional procedures in conjunction with the guidance of transrectal ultrasound involving the prostate gland in a clinical setting. Examples of such procedures include, but are not limited to, image fusion for diagnostic clinical examinations and procedures, soft tissue biopsies, and soft tissue ablations.
The iSR'obot Mona Lisa 2.0 provides 2D and 3D visualization of Ultrasound images and the ability to fuse and register these images with those from other imaging modalities such as Magnetic Resonance, etc. It also provides the ability to display a simulated image of an insertion tool on a computer monitor screen, the target organ, and the current and projected future path of the insertion tool taking into account patient movement. Other software features include multiplanar reconstruction, segmentation, image measurements, 2D/3D image registration, and reporting.
The iSR'obot Mona Lisa 2.0 is user-controlled, stereotaxic accessory intended to guide physicians in the planning and positioning of insertion tools, such as a needle or a probe, during image-guided diagnostic and interventional procedures involving the prostate gland in a clinical setting. The device displays the 2D live image feeds from commercially available ultrasound systems and constructs 3D ultrasound image stacks. The system allows the importation of an MRI image to create a model of patient prostate by providing fusion between Ultrasound and Magnetic Resonance Imaging (MRI). The system is compatible with commercially available ultrasound systems, transrectal ultrasound bi-plane probes, and commercially available needle devices. Other software features include multi-planar reconstruction, segmentation, image measurements and 2D/3D image registration.
The provided text for iSR'obot Mona Lisa 2.0 (K213411) focuses on demonstrating substantial equivalence to a predicate device and details non-clinical testing. It explicitly states, "There is no pre-market clinical investigation submitted for iSR'obot Mona Lisa 2.0." Therefore, there is no information available in this document regarding acceptance criteria for clinical performance, the results of a clinical study proving the device meets these criteria, or details related to human readers, sample sizes for test/training sets, or ground truth establishment in a clinical context.
However, the document does describe non-clinical system performance testing using phantoms. I can extract information related to those non-clinical tests.
Non-Clinical System Performance Testing (using phantom)
1. Acceptance Criteria and Reported Device Performance (Non-Clinical)
| Acceptance Criteria (Implied from Testing Purpose) | Reported Device Performance (Non-Clinical) |
|---|---|
| Ability to accurately position the needle after system calibration. | Testing conducted to demonstrate that after the system has been calibrated, the system is able to accurately position the needle. (Pass / Meets criteria implied) |
| Ability to adjust generated prostate models and planned needle position to compensate for patient movement during the procedure. | Testing conducted to demonstrate the adjustment of the generated prostate models and planned needle position to compensate for the patient movement during the procedure. (Pass / Meets criteria implied) |
| Ability to facilitate multi-needle positioning. | Testing conducted to demonstrate multi-needle positioning. (Pass / Meets criteria implied) |
Note: The document only states that these tests were "conducted to demonstrate" the listed functionalities. It does not provide specific numerical results or quantitative acceptance thresholds for these non-clinical tests in the provided summary. A "Pass / Meets criteria implied" is inferred based on the submission being cleared and the statement that "successful verification and non-clinical testing" was performed.
2. Sample Sizes Used for the Test Set and Data Provenance:
- Sample Size (Test Set): Not specified in the provided text. The tests were conducted using a "phantom."
- Data Provenance: The tests were non-clinical, using a "phantom." Therefore, there is no patient data provenance (country, retrospective/prospective).
3. Number of Experts Used to Establish Ground Truth and Qualifications:
- Number of Experts: Not applicable for non-clinical phantom testing.
- Qualifications of Experts: Not applicable.
4. Adjudication Method for the Test Set:
- Adjudication Method: Not applicable for non-clinical phantom testing.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:
- Was an MRMC study done? No. The document explicitly states, "There is no pre-market clinical investigation submitted for iSR'obot Mona Lisa 2.0."
- Effect size of human readers improving with AI vs. without AI assistance: Not applicable, as no MRMC study was conducted.
6. Standalone (Algorithm only without human-in-the-loop performance) Study:
- Was a standalone study done? Not explicitly mentioned as a separate formal study, but the "Non-clinical System Performance Testing" on a phantom would represent an algorithm/system-only performance test in a controlled environment, demonstrating the device's capabilities without direct human clinical intervention during the specified tasks (e.g., automated positioning accuracy). However, the device is marketed as "user-controlled, stereotaxic accessory intended to guide physicians," implying a human-in-the-loop for its clinical use.
7. Type of Ground Truth Used:
- Ground Truth Type: For the non-clinical phantom testing, the ground truth would typically be the precisely known or measured locations/trajectories within the phantom, established by engineering specifications, physical measurements, or other metrology techniques. The document refers to the system's "ability to accurately position the needle" and "adjustment... to compensate for the patient movement," which suggests a known target or reference from which accuracy/adjustment can be measured against.
8. Sample Size for the Training Set:
- Sample Size (Training Set): Not applicable or not specified in the provided text, as this document focuses on regulatory submission for a marketed device based on non-clinical testing and substantial equivalence, not detailing the development or training of specific AI components if they exist within the system beyond the mechanical guidance.
9. How the Ground Truth for the Training Set was Established:
- Ground Truth Establishment (Training Set): Not applicable or not specified.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo in blue, with the words "U.S. FOOD & DRUG ADMINISTRATION" in blue as well. The FDA is a federal agency responsible for regulating and supervising the safety of food, drugs, and other products.
Biobot Surgical Pte Ltd % Lim Yan Shin Regulatory Affairs 79 Ayer Rajah Crescent, #04-05 Singapore. Singapore 139955 SINGAPORE
December 22, 2021
Re: K213411
Trade/Device Name: iSR'obot Mona Lisa 2.0 Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulatory Class: Class II Product Code: IYO, ITX, LLZ, OIJ Dated: October 15, 2021 Received: October 19, 2021
Dear Lim Yan Shin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
{1}------------------------------------------------
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Jessica Lamb, Ph.D. Assistant Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
K213411
Device Name iSR'obot Mona Lisa 2.0
Indications for Use (Describe)
iSR'obot Mona Lisa 2.0 is a user-controlled, stereotaxic accessory intended to guide physicians in the planning and positioning of insertion tools, such as a third-party needle or a probe, during image-guided diagnostic and interventional procedures in conjunction with the guidance of transrectal ultrasound involving the prostate gland in a clinical setting. Examples of such procedures include, but are not limited to, image fusion for diagnostic clinical examinations and procedures, soft tissue biopsies, and soft tissue ablations.
The iSR'obot Mona Lisa 2.0 provides 2D and 3D visualization of Ultrasound images and the ability to fuse and register these images with those from other imaging modalities such as Magnetic Resonance, etc. It also provides the ability to display a simulated image of an insertion tool on a computer monitor screen, the target organ, and the current and projected future path of the insertion tool taking into account patient movement. Other software multiplanar reconstruction, segmentation, image measurements, 2D/3D image registration, and reporting.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW *
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for Biobot. The word "biobot" is written in lowercase letters. The "bio" portion of the word is in orange, and the "bot" portion of the word is in blue. The "bio" portion of the word is also slightly larger than the "bot" portion of the word.
510(k) Summarv
K213411
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
This 510(k) summary of Safety and Effectiveness information is submitted in accordance with the requirement of 21 CFR Part 807.87(h).
| Date: | October 15, 2021 |
|---|---|
| Submitter: | Biobot Surgical Pte Ltd79 Ayer Rajah Crescent,#04-05, Singapore 139955 |
| Primary Contact: | Lim Yan Shin, Regulatory AffairsBiobot Surgical Pte LtdCell: +65 97263992E-mail: yanshin.lim@ziggroup.com.sg |
| Secondary Contact: | Georgiann Keyport, Regulatory Consultant, U.S.Email: gkeyport@canopyregulatory.comCell: 952-994-8267 |
Product Identification
| Device Trade Name: | iSR'obot Mona Lisa 2.0 |
|---|---|
| Common / Usual Name: | System, image processing, radiological |
| Classification Names: | 892.1560 Ultrasonic pulsed echo imaging system892.1570 Diagnostic ultrasonic transducer |
| Product Code: | IYO, ITX, LLZ, OIJ |
| Manufacturer / Design | Biobot Surgical Pte Ltd |
| Location: | 79 Ayer Rajah Crescent,#04-05, Singapore 139955 |
Device Description
The iSR'obot Mona Lisa 2.0 is user-controlled, stereotaxic accessory intended to guide physicians in the planning and positioning of insertion tools, such as a needle or a probe, during image-guided diagnostic and interventional procedures involving the prostate gland in a clinical setting. The device displays the 2D live image feeds from commercially available ultrasound systems and constructs 3D ultrasound image stacks. The system allows the importation of an MRI image to create a model of patient prostate by providing fusion between Ultrasound and Magnetic Resonance Imaging (MRI). The system is compatible with commercially available ultrasound systems, transrectal ultrasound bi-
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the logo for Biobot. The word "biobot" is written in blue, with the "b" and "i" connected. Above the word is an orange oval shape, with a small dot on the upper left side. The logo is simple and modern.
plane probes, and commercially available needle devices. Other software features include multi-planar reconstruction, segmentation, image measurements and 2D/3D image registration.
Workstation
The workstation is connected to the ultrasound system via a standard cable and hardware connector and displays the 2D live image feed in a format that is compatible with the iSR 'obot Mona Lisa 2.0. Using the application software, the urologist or physician defines the apex and base limits of the prostate gland and the robotic arm moves the ultrasound probe within those limits to capture multiple 2D slices of the prostate gland to construct the 3D image stack. The urologist or physician may refine the constructed 3D image stack by indicating and confirming the planned lesion core or tumor location, anatomical markers within or around the prostate gland, and the prostate gland contour. In addition, the application software can utilize previously acquired images of the patient's prostate, which may include other image modalities like magnetic resonance images and register to this 3D image stack. The completed procedure information can be stored on a location selected by the urologist or physician, such as in the workstation or in a PACS server. The stored procedure information can be used for future review with the patient or examination. Previously stored biopsy procedural plan can be recalled and its 3D model may be aligned and registered to current 3D model of the prostate to facilitate planning of the interventional procedure.
Robotic Navigation Module
The robotic navigation module comprises of a robotic arm and bed rail stabilizer. The stabilizer is a mechanical device and is able to lock and release to position the robotic arm. One end of the stabilizer is first attached to the bed rail while the other end is used to mount the robotic arm so that the robotic arm is able to be positioned close to the patient's perineum while the patient is in a lithotomy position. The robotic arm is a motorized mechanical structure and has two key functions, which is to hold and move the ultrasound probe of a commercially available ultrasound system to display 2D live ultrasound image feeds and to orientate its needle guidance mechanism to facilitate insertion of a commercially available needle (based on a planned and simulated needle trajectory) by the urologist or physician. The movement of the ultrasound probe and the needle guidance mechanism is motorized. As a result, the workstation is able to construct and display a 3D image stack and rendered surface model of the prostate.
{5}------------------------------------------------
Image /page/5/Picture/1 description: The image shows the logo for Biobot Analytics. The logo features the word "biobot" in a sans-serif font. The "bio" portion of the word is in a gradient orange color, while the "bot" portion is in blue. The logo has a modern and clean design.
During the procedure, the real time 2D ultrasound image is visible on the iSR 'obot Mona Lisa 2.0 display. After the robotic arm has orientated its trajectory according to the planned location, the urologist or physician manually inserts the needle into the prostate via the needle guidance mechanism. The 2D live ultrasound image may be marked up to record the actual locations where the needle has been inserted. The system is able to pivot and facilitate re-insertion of the needle if the marked up actual location is distant from the planned location. The urologist or physician is able to observe prostate shift on live ultrasound image, re-register the prostate model and needle location plan to the live ultrasound prostate image.
Needle Guide Holder
The needle guide holder is designed to be used with the iSR obot Mona Lisa 2.0. It is a component installed on the robotic arm functioning as a channel for insertion tools to go through. The robotic arm has a motorized mechanism to close and open the needle guide holder in order to hold and release the insertion tools. The needle guide holder may be manufactured to fit insertion tools with varying diameters.
Disposables
The iSR 'obot Kit is intended to be used with the iSR'obot Mona Lisa 2.0 as a component of a system for performing transperineal prostate procedure. The kit consists of probe sheath, drape and biopsy papers. The probe sheath functions as a sheath to a third-party ultrasound probe for ultrasound scanning of the prostate organ.
| Predicate Device Name | Predicate 510(k) Submission Reference |
|---|---|
| iSR'obot Mona Lisa 1.0 | K203659 (Primary) |
| iSR'obot MRI-US Fusion | K161109 (Reference) |
| iSR'obot Biopsy Kit | K163502 (Reference) |
| Artemis | K162474 (Reference) |
Predicate Device Information and Comparison
Intended Use / Indications for Use
iSR'obot Mona Lisa 2.0 is a user-controlled, stereotaxic accessory intended to guide physicians in the planning and positioning of insertion tools, such as a third-party needle or a probe, during image-guided diagnostic and interventional procedures in conjunction with the guidance of transrectal ultrasound involving the prostate gland in a clinical setting.
{6}------------------------------------------------
Image /page/6/Picture/1 description: The image shows the logo for Biobot. The word "biobot" is written in a sans-serif font, with "bio" in a bright orange color and "bot" in a dark blue color. The "bio" portion of the logo is set against a larger orange oval shape, giving the impression of a stylized sun or planet.
Examples of such procedures include, but are not limited to, image fusion for diagnostic clinical examinations and procedures, soft tissue biopsies, and soft tissue ablations.
The iSR 'obot Mona Lisa 2.0 provides 2D and 3D visualization of Ultrasound images and the ability to fuse and register these images with those from other imaging modalities such as Magnetic Resonance, etc. It also provides the ability to display a simulated image of an insertion tool on a computer monitor screen, the target organ, and the current and projected future path of the insertion tool taking into account patient movement. Other software features include multi-planar reconstruction, segmentation, image measurements, 2D/3D image registration, and reporting.
Technology Characteristics Compared to Predicate Devices
iSR'obot Mona Lisa 2.0 employs the same fundamental scientific technology (design, function and specifications) as that of its legally marketed predicate device, iSR'obot Mona Lisa 1.0 (K203659).
Similarities in technology characteristics include:
- Platform-hosted motorized devices and are able to provide 2D and 3D views of . the prostate gland;
- Use the same technology to acquire a transrectal ultrasound image to plan and . guide a needle for diagnostic procedure;
- Control the trajectory and depth for needle placement via needle guiding • mechanism;
- . Fusion of Magnetic Resonance and Ultrasound images for mapping planning information of the prostate gland
- . Re-positioning of subsequent needle insertion for the same target lesion after the user has indicated the actual needle landing position from the prior insertion.
Modifications to iSR'obot Mona Lisa 2.0 include:
- The iSR'obot Mona Lisa 2.0 is intended for image-guided diagnostic and . interventional procedures while the legally marketed predicate device is intended only for image-guided diagnostic procedure;
- . Visualization of simulated images in an interventional procedure of 1) the lesions and their margins and 2) treatment zone;
- . Needle guide holder, which acts as a channel for insertion tool positioning, is detachable and can be cleaned and sterilized for subsequent use, and enables multi-needle insertion trajectory planning for interventional procedures;
{7}------------------------------------------------
Image /page/7/Picture/1 description: The image shows the logo for Biobot Analytics. The logo features the word "biobot" in a stylized font. The "bio" portion of the word is in orange, while the "bot" portion is in blue. The "o" in "bio" is shaped like an oval.
- . Patient movement adjustment function for re-alignment of the prostate model with the live-ultrasound image in the event that prostate shifts due to patient movement during a procedure;
- . Connectivity to picture archiving and communication system (PACS) to download DICOM images and download/upload of procedure case; and
- . Provide an offline post-procedure review
Other changes include minor user interface variations such as graphics user interface (GUI) design. These differences do not significantly affect the function or use of the device, nor do they raise new or additional safety risks.
These changes are being implemented as a product improvement effort and not due to a corrective action or field action.
iSR'obot Mona Lisa 2.0 has the following technological characteristics, similar to the Artemis (K162474):
- . Same intended use for insertion tool planning and navigation for ultrasound imageguided prostate diagnostic and interventional procedures.
- . Connecting to standard ultrasound system to display and acquire 2D live ultrasound images of the prostate gland
- Perform other viewing and imaging-processing function such as image segmentation, image multi planar reconstruction, image overlays, and measurements
- . Image registration and elastic fusion of ultrasound image with previously created MRI prostate model and/or prior biopsy plan on application software
- . Generate 2D/3D model of a prostate model and trajectory of insertion tools
- . Plan insertion tool positions on the fused prostate model by physicians and mark the actual position of insertion tools
- . Connectivity to PACS to download DICOM images and download/upload of procedure case
- Artemis has a needle guide mechanism attachment similar to the iSR'obot Mona . Lisa 2.0. which allows insertion of third-party insertion tools
The differences between iSR'obot Mona Lisa 2.0 and Artemis (K162474) are that:
- . Anatomical Access - iSR'obot Mona Lisa 2.0 is intended for insertion tools positioned transperineally while Artemis is intended for insertion tools positioned transperineally and transrectally procedure.
{8}------------------------------------------------
Image /page/8/Picture/1 description: The image shows the logo for Biobot. The logo consists of the word "biobot" in blue, with the "bio" portion of the word in a larger font size than the "bot" portion. To the left of the word "biobot" is an orange oval shape that is slightly tilted to the left.
- . Positioning of insertion tools - iSR'obot Mona Lisa 2.0 has an 8 axis motorized robotic arm that navigates the needle guide holder based on the clinician's insertion tool position plan. The Artemis has a semi-robotic arm (mechanical arm with encoders) that clinicians may control to track and visualize the insertion tool as it is being positioned. Despite the slight difference, the clinician is in control throughout and manually inserts the insertion tool for both devices.
- Adjustment of prostate model in the event of patient movement iSR'obot ● Mona Lisa 2.0 provides an adjustment panel for users to manually adjust the prostate model to align with the ultrasound live image of the shifted prostate. Artemis tracks the position and orientation of the ultrasound probe, and users mark landmark features on the ultrasound live image to enable its software to automatically adjust the prostate model to align with the ultrasound live image of the shifted prostate.
- Information for active surveillance - Artemis is intended to be used for patients in active surveillance to keep track of previous procedures information and outcomes. iSR'obot Mona Lisa 2.0 allows previous procedures information to be accessed for patients under active surveillance, but the histopathological outcome is not currently captured in the software.
The technological characteristic above are features that assists physicians to plan and insert an insertion tool. The physician has full control of the tasks to be performed. According to the risk analysis, non-clinical performance tests, device verification and validation tests, the above differences do not result in additional or increase to existing known risks for iSR'obot Mona Lisa 2.0.
Substantial Equivalence
The technological characteristics such as intended use, method of operation, general function and application of the iSR'obot Mona Lisa 2.0 are equivalent to the primary predicate iSR'obot Mona Lisa 1.0 (K203659),
iSR'obot Mona Lisa 1.0 (K203659), iSR'obot MRI-US Fusion (K161109) and iSR'obot Biopsy Kit (K163502) shall be collectively known as iSR 'obot Mona Lisa 1.0 System.
Risk analysis was conducted to evaluate the modifications and features update in iSR'obot Mona Lisa 2.0. All verification and validation activities were performed and results demonstrated substantial equivalence. Table 1 indicates the comparison between the subject device and predicate devices.
{9}------------------------------------------------
Image /page/9/Picture/1 description: The image shows the word "biobot" in a stylized font. The word is written in lowercase letters. The "bio" portion of the word is colored in orange, while the "bot" portion is in blue. The orange color appears to fade into the blue color.
| Table 1: Comparison Between Predicate Devices and Subject Device iSR'obot Mona Lisa2.0 | |||
|---|---|---|---|
| TechnologicalCharacteristic | Reference Device: | Predicate Device: | Submitted Device: |
| Eigen's Artemis(K162474) | iSR'obot Mona Lisa1.0 System (Primary -K203659, Reference -K161109, K163502) | iSR'obot Mona Lisa2.0 | |
| Intended Use | Artemis along with theNeedle GuideAttachment is used forimage-guidedinterventional anddiagnostic proceduresof the prostate gland. Itprovides 2D and 3Dvisualization ofUltrasound (US)images and the abilityto fuse and registerthese images with thosefrom other imagingmodalities such asUltrasound, MagneticResonance, ComputedTomography, etc. Italso provides the abilityto display a simulatedimage of a trackedinsertion tool such as abiopsy needle,guidewire or probe on acomputer monitorscreen that showsimages of the targetorgan and the currentand the projected futurepath of theinterventionalinstrument taking intoaccount patientmovement. Thesoftware also providesa virtual grid on the liveultrasound for | iSR'obot Mona Lisa 1.0is intended for use bytrained urologist orphysician to performthe computer-assistedtransperineal prostatebiopsy under transrectalultrasound guidance.The device serves as abiopsy needle guideonly. It shall be used inconjunction with a thirdparty ultrasoundmachine and endorectalprobe that supports B-Mode, and a third partyprostate biopsy gun andneedle. The insertion ofbiopsy needle will bedone by urologist. Thepatient is administeredgeneral anesthesia andplaced in a lithotomyposition. | iSR'obot Mona Lisa2.0 is a user-controlled,stereotaxic accessoryintended to guidephysicians in theplanning andpositioning of insertiontools, such as a third-party needle or a probe,during image-guideddiagnostic andinterventionalprocedures inconjunction with theguidance of transrectalultrasound involvingthe prostate gland in aclinical setting.Examples of suchprocedures include, butare not limited to,image fusion fordiagnostic clinicalexaminations andprocedures, soft tissuebiopsies, and soft tissueablations.The iSR'obot MonaLisa 2.0 provides 2Dand 3D visualization ofUltrasound images andthe ability to fuse andregister these imageswith those from otherimaging modalitiessuch as Magnetic |
| performing systematicsampling of the targetorgan. Other softwarefeatures include patientdata management,multi-planarreconstruction,segmentation, imagemeasurements, 2D/3Dimage registration,reporting, andpathology management.Artemis is intended fortreatment planning andguidance for clinical,interventional and/ordiagnostic procedures.The device is intendedto be used ininterventional anddiagnostic proceduresin a clinical setting.Example proceduresinclude, but are notlimited to image fusionfor diagnostic clinicalexaminations andprocedures, soft tissuebiopsies, soft tissueablations andplacement of fiducialmarkers. Artemis isalso intended to be usedfor patients in activesurveillance to keeptrack of previousprocedures informationand outcomes. | Resonance, etc. It alsoprovides the ability todisplay a simulatedimage of an insertiontool on a computermonitor screen, thetarget organ, and thecurrent and projectedfuture path of theinsertion tool takinginto account patientmovement. Othersoftware featuresinclude multi-planarreconstruction,segmentation, imagemeasurements, 2D/3Dimage registration, andreporting. | ||
| Product Code | LLZ | IYO, ITX, LLZ, OIJ | IYO, ITX, LLZ, OIJ |
| Class | II | II | II |
| TargetAnatomy | Prostate | Prostate | Prostate |
| AnatomyAccess | TransperinealTransrectal | TransperinealNot available | TransperinealNot available |
| Patientpopulation | Patients for a biopsyprocedure | Patients for a biopsyprocedure | Patients for a biopsyprocedure |
| Patients for aninterventionalprocedure | Patients for aninterventionalprocedure | ||
| Patients in activesurveillance | |||
| Clinical Utility | Soft tissue biopsies, | Soft tissue biopsies | Soft tissue biopsies |
| Soft tissue ablations | Soft tissue ablations | ||
| Placement of fiducialmarkers | |||
| Pathology management | |||
| Patient datamanagement | |||
| Software | |||
| Window OS | Yes | Yes | Yes |
| MedicalImagingSoftware | Yes | Yes | Yes |
| Compliancewith FDACybersecurity | Yes | Yes | Yes (Updated) |
| Image Display | |||
| Multi-ModalitySupport | Yes | Yes | Yes |
| General Image2D/3D Review | Yes | Yes | Yes |
| 3D RenderingView | Yes | Yes | Yes |
| Live 2DUltrasound | Yes | Yes | Yes |
| Image Processing |
{10}------------------------------------------------
Image /page/10/Picture/1 description: The image shows the logo for Biobot Analytics. The logo consists of the word "biobot" in a sans-serif font, with the "bio" portion in a vibrant orange color and the "bot" portion in a darker blue color. To the left of the word "biobot" is an orange oval shape, which appears to be a stylized representation of a droplet or a cell.
{11}------------------------------------------------
Biobot Surgical Pte. Ltd
Image /page/11/Picture/1 description: The image shows the word "biobot" in a stylized font. The word is written in a blue color, and there is an orange oval shape behind the word. The oval shape is positioned so that it appears to be behind and slightly to the left of the word.
{12}------------------------------------------------
Biobot Surgical Pte. Ltd
Image /page/12/Picture/1 description: The image shows the logo for Biobot Analytics. The logo features the word "biobot" in a stylized font. The "bio" portion of the word is in orange, while the "bot" portion is in blue. There is also an orange oval shape behind the word "bio".
| GlandSegmentation | Yes | Yes | Yes | |||
|---|---|---|---|---|---|---|
| ImageRegistration | Yes | Yes | Yes | |||
| RigidRegistration | Yes | Yes | Yes | |||
| ElasticRegistration | Yes | Yes | Yes | |||
| Multi-PlanarReformatting | Yes | Yes | Yes | |||
| Connectivity | ||||||
| DICOMImport/Export | Yes | Not available | Yes (updated) | |||
| Review Tools | ||||||
| Standard ImageViewing Tools | Yes | Yes | Yes | |||
| MeasurementTools | Yes | Yes | Yes | |||
| AnnotationTools | Yes | Yes | Yes | |||
| SegmentationTools | Yes | Yes | Yes | |||
| ReportingTools | Yes | Yes | Yes | |||
| Image Overlays | Yes | Yes | Yes (updated) | |||
| Post ProcedureReview | Yes | Not available | Yes | |||
| Planning & Navigation | ||||||
| Import PriorPlans | Yes | Yes | Yes | |||
| Import/AddTargets | Yes | Yes | Yes | |||
| Plan / MarkLocations | Yes | Yes | Yes (updated) |
{13}------------------------------------------------
Image /page/13/Picture/1 description: The image shows the logo for Biobot. The logo consists of the word "biobot" in blue, with the "bio" part of the word in a slightly darker shade of blue. To the left of the word is an orange oval shape, with a darker orange dot inside of it. The oval shape is positioned so that it appears to be behind the word "biobot".
| NavigationType | Mechanical | Electromechanical | Electromechanical |
|---|---|---|---|
| Third-Party Devices Compatibility | |||
| Insertion Tools(e.g needlesand probes) | Yes | Yes | Yes |
| UltrasoundSystems | Yes | Yes | Yes |
| Components | |||
| Hardware | • Workstation• Mechanical Arm forpositioning ofinsertion tool | • Workstation• Mechanical Arm forpositioning ofinsertion tool• Stabilizer | • Workstation• Mechanical Arm forpositioning ofinsertion tool• Stabilizer |
| Disposables | Not available | Proprietary Disposables | Proprietary Disposables |
Safety and Effectiveness
The labelling contains instructions for use and necessary cautions, warnings and notes to provide for safe and effective use of the device. Risk management is ensured via Biobot Surgical's design control procedures and application of risk management procedure, which is used to identify and mitigate potential hazards. These potential hazards are controlled through the product development process, verification and validation testing, systematic clinical literature review and clinical effects analysis (CEA) to ensure safe profile of iSR'obot Mona Lisa 2.0.
Nonclinical Testing and Performance Information
Biobot performed the following testing to ensure safety and effectiveness of iSR'obot Mona Lisa 2.0:
- Design and System Verification To ensure iSR'obot Mona Lisa 2.0 meets the . specifications and its intended purpose
- . Software Verification and Validation - To ensure the all software meets the specifications and the intended purpose. Software life cycle process is in accordance with IEC 62304:2006+A1:2015 Ed 1.1
- Usability Testing Testing conducted in accordance with IEC 623661: . 2015+AMD1: 2020 Ed 1.1 and FDA guidance Applying Human Factors and Usability Engineering to Medical Devices
{14}------------------------------------------------
Biobot Surqical Pte. Ltd
Image /page/14/Picture/1 description: The image shows the logo for Biobot Analytics. The logo features the word "biobot" in a stylized font. The "bio" portion of the word is in a bright orange color and is slightly larger than the "bot" portion, which is in blue. The orange section has a gradient effect, making it appear three-dimensional.
- . Cybersecurity Testing - Testing conducted in accordance with ANSI UL 2900-1 and ANSI UL 2900-2-1
- . Non-clinical System Performance Testing (system level testing using phantom)
- Testing conducted to demonstrate that after the system has been calibrated, the O system is able to accurately position the needle.
- Testing conducted to demonstrate the adjustment of the generated prostate models o and planned needle position to compensate for the patient movement during the procedure.
- Testing conducted to demonstrate multi-needle positioning о
- Biocompatibility testing - Testing conducted to ensure biocompatibility of Needle Guide Holder.
- ISO 10993-1:2018 O
- ISO 10993-5: 2008 O
- o ISO 10993-10: 2010
- ISO 10993-11: 2017 O
- . Reprocessing Validation - to validate the cleaning and sterilization procedure for Needle Guide Holder. Testing is conducted in accordance with AAMI TIR12:2010 and AAMI TIR30:2011/ (R)2016.
- . Other Non-Clinical Tests
- IEC 60601-1:2005 Ed 3.1 o
- IEC 60601-1-2:2014 Ed 4 O
- IEC 60601-1-6:2013 Ed 3.1 O
- ISO 14971:2019 O
- ISTA 3A 2018 O
- ISTA 3B 2017 O
- AAMI TIR28 o
Clinical Information
There is no pre-market clinical investigation submitted for iSR'obot Mona Lisa 2.0.
Conclusion
Comparison of the intended use, indications for use, technological characteristics, and performance specifications demonstrate the functional equivalence of iSR'obot Mona Lisa 2.0 to the predicate device iSR'obot Mona Lisa 1.0.
Based on the conformance to standards, development under Biobot's quality system, and the successful verification and non-clinical testing, iSR'obot Mona Lisa 2.0 does not raise any new safety and/or effectiveness concerns. Biobot believes that the iSR'obot Mona
{15}------------------------------------------------
Biobot Surgical Pte. Ltd
100
Image /page/15/Picture/1 description: The image shows the logo for Biobot Analytics. The logo features the word "biobot" in a stylized, lowercase font. The "bio" portion of the word is in orange, while the "bot" portion is in blue. The orange section appears to be a gradient, with a lighter shade at the top and a darker shade at the bottom.
Lisa 2.0 is safe and effective, and performs in a substantially equivalent manner to the predicate device iSR'obot Mona Lisa 1.0.
§ 892.1560 Ultrasonic pulsed echo imaging system.
(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.